OM
Opaleye Management Inc. cut its KTTA stake below 5%
Opaleye Management Inc. reported owning 0% of Pasithea Therapeutics Corp. (KTTA) in a Schedule 13G filed Nov 6, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13G